Search - tctmd.com

Displaying 361 - 380 of 684

Sort: Relevancy | Date

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

Presenter: Robert Bonow

September 28, 2019

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

Presentation TCT 2019

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Felix Mahfoud

September 28, 2019

Presentation TCT 2019

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Ajay Kirtane

September 28, 2019

Presentation TCT 2019

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Presenter: Michael Boehm

September 28, 2019

Presentation TCT 2019

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Presenter: Bruno Scheller

September 28, 2019

Presentation TCT 2019

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

Presenter: Matthew Price

September 27, 2019

Presentation TCT 2019

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

Presenter: Manesh Patel

September 27, 2019

Presentation TCT 2019

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Presenter: Gregg Stone

September 27, 2019

Presentation TCT 2019

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Presenter: Anthony Gershlick

September 27, 2019

Presentation TCT 2019

Industry Perspectives on Controlled Trials for Shock Devices

Presenter: Seth Bilazarian

September 27, 2019

Presentation TCT 2019

Industry View on Controlled Trials for Heart Failure and Shock Devices

Presenter: William Abraham

September 27, 2019

Innovation Gone Wild - Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presentation TCT 2019

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Presenter: Tamim Nazif

September 27, 2019

Presentation TCT 2019

Experience on the Early Feasibility Study (US Industry’s View)

Presenter: Robert Thatcher

September 26, 2019

Presentation TCT 2019

Experience on the Global Clinical Trial (Japanese Industry’s View)

Presenter: Daiki Yasuhara

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For an Early Feasibility Study in the US

Presenter: Hiren Mistry

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Presenter: Mitsuru Yuba

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Advertisement

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

TAVR in Low-Risk Patients: Strengths and Limitations of the Low-Risk Trials

When Trials Disagree: The COAPT/MITRA-FR Case Study

Update on Target BP Trials Program (Chemical Renal Denervation): Lessons Learned, Ongoing Efforts

Update on RADIANCE Trials Program (Ultra-Sound Renal Denervation): Lessons Learned, Ongoing Efforts

Update on SPRYRAL Trials Program (Radiofrequency Renal Denervation): Lessons Learned, Ongoing Efforts

Death Following DCB Use – Not! Clinical Data from Coronary Trials

Intravenous Platelet Inhibition for PCI: Drug Description and Clinical Outcomes From Randomized Trials and Registries

FFR-CT State of the Art Clinical Study Evidence and Ongoing/Planned Trials

ABSORB 5-Year Pooled Analysis: Improving Very Late Outcomes of the Absorb Bioresorbable Scaffold in Coronary Artery Disease From 4 Randomized Trials

Designing Controlled Trials for Shock Devices: Population Targets and Safety and Effectiveness Considerations

Industry Perspectives on Controlled Trials for Shock Devices

Industry View on Controlled Trials for Heart Failure and Shock Devices

Next-Generation TRIGUARD Cerebral Embolic Protection During TAVR: Technology Review and Status of Ongoing Clinical Trials

Experience on the Early Feasibility Study (US Industry’s View)

Experience on the Global Clinical Trial (Japanese Industry’s View)

The Basic Regulation Pathway For an Early Feasibility Study in the US

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Polymer-Free DES: Lessons Learned From Recent Trials

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content